Response by Elliott et al to Letter Regarding Article, "Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy"
- PMID: 35748240
- DOI: 10.1161/CIRCHEARTFAILURE.122.009637
Response by Elliott et al to Letter Regarding Article, "Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy"
Comment on
-
Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy.Circ Heart Fail. 2022 Jan;15(1):e008193. doi: 10.1161/CIRCHEARTFAILURE.120.008193. Epub 2021 Dec 20. Circ Heart Fail. 2022. PMID: 34923848 Free PMC article.
-
Letter by Baldovino et al Regarding Article, "Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy".Circ Heart Fail. 2022 Jul;15(7):e009617. doi: 10.1161/CIRCHEARTFAILURE.122.009617. Epub 2022 Jun 24. Circ Heart Fail. 2022. PMID: 35748294 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials